HI
UTHR icon

Handelsinvest Investeringsforvaltning’s United Therapeutics UTHR Stock Holding History

Handelsinvest Investeringsforvaltning’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$283K Sell
1,230
-639
-34% -$144K 0.14% 181
2023
Q4 		$411K Buy
+1,869
New +$431K 0.17% 177

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Handelsinvest Investeringsforvaltning's UTHR Position: Q1 2024 in Review

Handelsinvest Investeringsforvaltning reduced its United Therapeutics (UTHR) stake by 34% in Q1 2024, selling an estimated $144K and leaving 1,230 shares worth $283K. The position accounts for 0.14% of the portfolio, ranked #181.

Handelsinvest Investeringsforvaltning first reported a position in UTHR in Q4 2023 and has held it in 2 quarters since. The position peaked at $411K in Q4 2023. 525 funds tracked by Wall St. Rank hold UTHR as of Q1 2024.

  • Handelsinvest Investeringsforvaltning held 1,230 shares of United Therapeutics worth $283K as of Q1 2024.
  • Handelsinvest Investeringsforvaltning sold 639 United Therapeutics shares in Q1 2024, an estimated $144K.
  • United Therapeutics made up 0.14% of Handelsinvest Investeringsforvaltning's portfolio in Q1 2024, its #181 holding.
  • Handelsinvest Investeringsforvaltning first reported a position in United Therapeutics in Q4 2023 and has held it in 2 quarters since.
  • Handelsinvest Investeringsforvaltning's United Therapeutics position peaked at $411K in Q4 2023.
  • 525 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2024.

Based on Handelsinvest Investeringsforvaltning's 13F filing for Q1 2024, filed 19 Apr 2024.